Literature DB >> 6252603

[The incidence of antibodies against hepatitis A virus in various age groups in the Basle population 1978-79].

W Stadelmann, M Gasser, H Löffler.   

Abstract

In a study on the prevalence of hepatitis A virus (HAV) exposure among the Basel population in 1978/79, 763 sera matched for age were tested for HAV antibodies by radioimmunassay (HAVAB). Sera of patients with a recent history of liver disease were not included. The results show that the prevalence of HAV antibodies increases with age, a situation similar to that in poliomyelitis before vaccination. The prevalence of HAV antibodies rises from 15% in the 11-20 year age group to 90% in the over-71 age group. The fall in HAV exposure with decreasing age is attributed to a decline in infections due to improvements in hygienic standards during this century, and especially since World War II. The average prevalence of HAV antibodies found in this study is 52%. The results are partly influenced by the high proportion of subjects originating from foreign countries among the population investigated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6252603

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  4 in total

1.  Hepatitis A virus antibodies in Belgium: relationship between prevalence and age.

Authors:  R Vranckx; L Muylle
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

2.  Prevalence of hepatitis A antibodies in Swiss travellers.

Authors:  S Studer; H I Joller-Jemelka; R Steffen; P J Grob
Journal:  Eur J Epidemiol       Date:  1993-01       Impact factor: 8.082

3.  Serodiagnosis of viral hepatitis A: rise in antibody titre and evaluation of three methods for detecting early and late antibodies.

Authors:  C Girardet; R Peitrequin; P C Frei
Journal:  Experientia       Date:  1983-08-15

4.  [To which travelers abroad should immunization against hepatitis be recommended?].

Authors:  M Apothéloz; P J Grob; R Steffen; M Schär
Journal:  Soz Praventivmed       Date:  1982-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.